Assessment of the oncological outcomes of three different bacillus Calmette–Guérin strains in patients with high-grade T1 non-muscle-invasive bladder cancer

OBJECTIVE: : To determine whether there are significant differences in oncological outcomes between three different bacillus Calmette–Guérin (BCG) strains used for adjuvant intravesical immunotherapy in patients with high-grade T1 (T1HG) non-muscle-invasive bladder cancer (NMIBC). PATIENTS AND METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowak, Łukasz, Krajewski, Wojciech, Moschini, Marco, Chorbińska, Joanna, Poletajew, Sławomir, Tukiendorf, Andrzej, Muilwijk, Tim, Joniau, Steven, Tafuri, Alessandro, Antonelli, Alessandro, Orlando, Rossella, Di Trapani, Ettore, Alvarez-Maestro, Mario, Simone, Giuseppe, Zamboni, Stefania, Simeone, Claudio, Marconi, Maria Cristina, Mastroianni, Riccardo, Piszczek, Radosław, Xylinas, Evanguelos, Zdrojowy, Romuald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Management of NMIBC
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954505/
https://www.ncbi.nlm.nih.gov/pubmed/33763252
http://dx.doi.org/10.1080/2090598X.2021.1874628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954505/
https://www.ncbi.nlm.nih.gov/pubmed/33763252
http://dx.doi.org/10.1080/2090598X.2021.1874628

Ejemplares similares